Disruption of estrogen receptor beta’s DNA binding domain impairs its tumor suppressive effects in triple negative breast cancer

por Aspros, Kirsten G. M., Emch, Michael J., Wang, Xiyin, Subramaniam, Malayannan, Hinkle, Megan L., Rodman, Esther P. B., Goetz, Matthew P., Hawse, John R.
Publicado 2023

Nuclear GSK-3β and Oncogenic KRas Lead to the Retention of Pancreatic Ductal Progenitor Cells Phenotypically Similar to Those Seen in IPMN

por Ding, Li, Roeck, Kaely, Zhang, Cheng, Zidek, Brooke, Rodman, Esther, Hernandez-Barco, Yasmin, Zhang, Jin-San, Bamlet, William, Oberg, Ann, Zhang, Lizhi, Bardeesy, Nabeel, Li, Hu, Billadeau, Daniel
Publicado 2022

Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB/p65 signaling in triple negative breast cancer

por Aspros, Kirsten G. M., Carter, Jodi M., Hoskin, Tanya L., Suman, Vera J., Subramaniam, Malayannan, Emch, Michael J., Ye, Zhenqing, Sun, Zhifu, Sinnwell, Jason P., Thompson, Kevin J., Tang, Xiaojia, Rodman, Esther P. B., Wang, Xiyin, Nelson, Adam W., Chernukhin, Igor, Hamdan, Feda H., Bruinsma, Elizabeth S., Carroll, Jason S., Fernandez-Zapico, Martin E., Johnsen, Steven A., Kalari, Krishna R., Huang, Haojie, Leon-Ferre, Roberto A., Couch, Fergus J., Ingle, James N., Goetz, Matthew P., Hawse, John R.
Publicado 2022